James Peterson
Overview
Explore the profile of James Peterson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
1629
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dhingra M, Peterson J, Hedrick J, Pan J, Neveu D, Jordanov E
Vaccine
. 2025 Feb;
52:126912.
PMID: 39999539
No abstract available.
2.
Aliperti C, Steckenrider J, Sattari D, Peterson J, Bell C, Zifchock R
Sensors (Basel)
. 2024 Dec;
24(23).
PMID: 39685957
The purpose of this paper is to describe ongoing research on appropriate instrumentation and analysis techniques to characterize postural stability, postural agility, and dynamic stability, which collectively comprise the postural...
3.
Peterson J, Galarza K, Bchir S, Zocchetti C, Bertrand-Gerentes I, Zambrano B
Pediatr Res
. 2024 Dec;
PMID: 39672823
Immune persistence following primary vaccination with a single dose of meningococcal quadrivalent conjugate vaccines, MenACYW-TT/MCV4-CRM, at age 10-12 years was demonstrated. Most participants primed with MenACYW-TT and MCV4-CRM maintained seroprotective...
4.
Peterson J, Drazan D, Moughan B, Maguire J, Zolotas L, Maansson R, et al.
Vaccine
. 2024 Nov;
43(Pt 1):126469.
PMID: 39520893
Background: Vaccination against 5 prominent meningococcal serogroups (A/B/C/W/Y) is necessary for broad disease protection. We report immunopersistence through 4 years after a 2-dose (6-month interval) pentavalent MenABCWY primary vaccine series...
5.
Alves C, Goldstein A, Peterson J, Vossough A
AJNR Am J Neuroradiol
. 2024 Aug;
45(8):E32-E33.
PMID: 39122461
No abstract available.
6.
Zambrano B, Peterson J, Deseda C, Julien K, Spiegel C, Seyler C, et al.
Pediatr Res
. 2023 Oct;
95(4):1159.
PMID: 37853068
No abstract available.
7.
DiVito D, Wellik A, Burfield J, Peterson J, Flickinger J, Tindall A, et al.
Neurotherapeutics
. 2023 Sep;
20(6):1723-1745.
PMID: 37723406
We sought to prospectively characterize the nutritional status of adults ≥ 19 years (n = 22, 27% males) and children (n = 38, 61% male) with genetically-confirmed primary mitochondrial disease...
8.
Peterson J, Drazan D, Czajka H, Maguire J, Pregaldien J, Seppa I, et al.
Lancet Infect Dis
. 2023 Aug;
23(12):1370-1382.
PMID: 37579773
Background: Meningococcal serogroups A, B, C, W, and Y cause nearly all meningococcal disease, and comprehensive protection requires vaccination against all five serogroups. We aimed to assess the immunogenicity and...
9.
Remich S, Kitchin N, Peterson J, Li P, Pride M, Brock L, et al.
J Infect Dis
. 2023 Aug;
229(2):367-375.
PMID: 37531657
Background: This phase 2 extension explored the long-term antibody persistence of an investigational Clostridioides difficile vaccine and the safety, tolerability, and immunogenicity of dose 4 approximately 12 months post-dose 3....
10.
Zambrano B, Peterson J, Deseda C, Julien K, Spiegel C, Seyler C, et al.
Pediatr Res
. 2023 Mar;
94(3):1035-1043.
PMID: 36899125
Background: The immunogenicity and safety of a booster dose of tetanus toxoid-conjugate quadrivalent meningococcal vaccine (MenACYW-TT), alone or co-administered with MenB vaccine, were assessed in healthy 13-25-year olds who received...